Raj Bawa
Adjunct Faculty, Biology Department
Education and Training
M.S., Rensselaer Polytechnic Institute, Troy, New York
Ph.D., Rensselaer Polytechnic Institute, Troy, New York
Contact
E-mail: bawa@bawabiotech.com; rbawa@nvcc.edu
Tel: (703) 582-1745; (703) 723-0034
Fax: (571) 223-1844
Websites: http://lifeboat.com/ex/bios.raj.bawa
http://www.bawabiotech.com/
Mail Office: Bawa Biotechnology Consulting LLC, 21005 Starflower Way, Ashburn, VA 20147
Biography
Dr. Raj Bawa is President of Bawa Biotechnology Consulting LLC, a biotechnology and patent law firm founded in 2002 and based in Ashburn, Virginia. He is a biochemist and microbiologist by training and is a registered patent agent licensed to practice before the US Patent and Trademark Office (PTO). He specializes in all aspects of biotechnology, nanotechnology and pharmaceutical patent law, including prosecution, patent strategy, application drafting, prior art searching, freedom-to-operate searching and technology research opinions. Dr. Bawa is an Adjunct Associate Professor at Rensselaer Polytechnic Institute in Troy, New York as well as an Adjunct Professor of Natural and Applied Sciences at the Extended Learning Institute of Northern Virginia Community College in Annandale, Virginia. He serves as a Senior Scientist at SynerGene Therapeutics, Inc. in Potomac, Maryland. Currently, he is the Principle Investigator of two National Cancer Institute/SBIR contracts titled “A Targeted Nanocomplex for Early Detection of Lung Cancer” and “Targeted Nanocomplexed Iron Oxide for Early Detection with Concurrent Hyperthermia Treatment of Cancer.” Previously he held various positions at the PTO, including Primary Examiner (6 years); Supervisory Patent Examiner (acting); and Instructor at the US Patent Academy.
Dr. Bawa has authored 60 scientific, legal and business publications and has presented at over 100 conferences and symposia worldwide. He has served as an NIH grant reviewer and participated in NSF’s merit review process. He is a Life Member of Sigma Xi, Founding Director of the American Society for Nanomedicine, Advisory Board Member of the Lifeboat Foundation, Advisory Board Member of the Albany Law School Center for Law & Innovation, Global Advisory Council Member of the World Future Society, and Board Member of the RAA Board of Trustees. Presently, Dr. Bawa serves on the editorial boards of the following peer-reviewed journals: International Journal of Nanomedicine; Cancer Nanotechnology- Basic, Translational and Clinical Research; Recent Patents on Biomedical Engineering; Nanotechnology Law and Business. He is an Associate Editor of two peer-reviewed journals: Journal of Bionanoscience and Nanomedicine: NBM. He is Co-Editor of two books titled “Clinical Nanomedicine - from Bench to Bedside” (Pan Stanford Publishing, 2010) and “Nanotechnology- Law, Business and Commercialization” (Pan Stanford Publishing, 2010) and serves as a Section Editor of the “Biomedical Engineering Handbook, 4th edition” (CRC Press/Taylor Francis, 2011). His biographical record appears in the 2010 edition of Marquis Who's Who in the World. Some of Dr. Bawa’s awards include: Innovations Prize from the Institution of Mechanical Engineers, London, UK (2009); Appreciation Award from the Undersecretary of Commerce, Washington, DC (2001); Research Fellowship and Teaching Assistantship from Rensselaer (1985-90); Director’s Award (2001) and Key Award (2005) from Rensselaer’s Office of Alumni Relations.
Recent Publications
Bawa, R. and S. Johnson. (2010). The ethical implications of nanomedicine must be considered. In: Longwith, J. (editor), Nanotechnology, Greenhaven Press, Farmington Hills, MI, 187-197.
Bawa, R. (2010). The stem cell patent landscape: an expert opinion. Expert Opinion on Therapeutic Patents (in preparation)
Bawa, R. (2010). The Blood-Brain Barrier. In: D. Guston, J.G. Golson (editors). Encyclopedia of Nanoscience and Society, SAGE Publications, Inc., Thousand Oaks, CA (in press).
Bawa, R. (2009). Nanopharmaceuticals. In: D. Luscombe and P. D. Stonier (editors), Clinical Research Manual, 2nd edition, Euromed Communications, Haslemere, England, Supplement 27, S27.1- S27.20.
Bawa, R. (2009). Nanopharmaceuticals for drug delivery – a review. Touch Briefings 6:122-127.
Bawa, R. (2009). NanoBiotech 2008: Exploring global advances in nanomedicine. Nanomedicine: NBM 5:5-7.
Bawa, R. (2009). Patenting inventions in bionanotechnology: A primer for scientists and lawyers. In: D. E. Reisner (editor). Bionanotechnology: Global Prospects, CRC Press, Boca Raton, FL 309-337.
Bawa, R. (2008). Nanoparticle-based therapeutics in humans - a survey. Nanotechnology Law & Business 5(2):135-155.
Bawa, R., S. Melethil, W. J. Simmons and D. Harris. (2008). Nanopharmaceuticals – patenting issues and FDA regulatory challenges. American Bar Association SciTech Lawyer 5(2):10-15.
Bawa, R. (2007). Special Report - Patents and nanomedicine. Nanomedicine 2(3):351-374.
Harris, D. and R. Bawa. (2007). The carbon nanotube patent landscape in nanomedicine: an expert opinion. Expert Opinion on Therapeutic Patents 17(9):1165-1174.
Bawa, R. (2007). Nanotechnology patent proliferation and the crisis at the US Patent Office. Albany Law Journal of Science and Technology 17(3):699-735.
Bawa, R. and S. Johnson. (2007). The ethical dimensions of nanomedicine. The Medical Clinics of North America 91(5):881–887.
O’Neill, S., K. Hermann, M. Klein, J. Landes and R. Bawa. (2007). Broad claiming in nanotechnology patents: Is litigation inevitable? Nanotechnology Law and Business 4(1):595-606.
Bawa, R. (2005). Patenting nanomedicine: a catalyst for commercialization? Small Times 5(8):16.
Bawa, R. (2005). Editorial Commentary - Will the nanomedicine “patent land grab” thwart commercialization? Nanomedicine: NBM 1:346-350.
